In the aftermath of the Dobbs v. Jackson Women’s Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been used to induce abortions.
How can health care providers and pharmacies navigate these new restrictions?
On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements.
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact Kelli Sakalousky at email@example.com and mention whether you were at home or working within a corporate network. We’d also love to hear your suggestions for future episode topics.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition each week on LinkedIn, Facebook, YouTube, Instagram, and Twitter, and your connections can subscribe for email notifications.